Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, received an up to $21M award to lead a project to develop next-generation models of drug toxicity to advance safer therapeutics and reduce reliance on animal testing.
The company has teamed up with Amgen, Cincinnati Children’s Hospital Medical Center, Baylor College of Medicine, and Torch Bio, a University of Michigan Medical School spinout company, to use AI trained on data from advanced human model systems to build toxicity prediction models…